Opinion
2:19-cv-01332-KJD-NJK
01-17-2023
ORDER
Kent J. Dawson United States District Judge
Presently before the Court is Plaintiff's Motion in Limine No. 2 (#98) to preclude or limit reference to medical liens or any other collateral source of payment. Defendants filed a response in opposition (#108).
I. Background
This action arises from a motor vehicle accident on September 9, 2017. Plaintiff Alexis Lee (“Lee”) was driving an economy-sized Hyundai Sonata and Defendant Dino Dennison (“Dennison”) was driving a semi-truck as an employee of Defendant Knight Transportation (“Knight”) when the two vehicles collided. While Defendants have generally accepted liability, the parties still dispute the amount and causation of damages alleged by Plaintiff.
Plaintiff's second motion in limine argues that “Any evidence of reference to medical liens should be strictly limited to asking doctors who still hold their liens at the time of trial: (1) what a medical lien is; and (2) whether their treatment was offered on such a medical lien. Any further questioning along these lines violates would violate [sic] the collateral source rule and would cause unfair prejudice to plaintiffs.” Doc. No. 98 at p. 6, l. 15-19.
II. Analysis
A motion in limine is a procedural mechanism made in advance to limit testimony or evidence in a particular area” and is “entirely within the discretion of the Court.” Diamond X Ranch, LLC v. Atlantic Richfield Co., No. 3:13-cv-00570-MMD-WGC, 2018 WL 2127734, at *1 (D. Nev. May 8, 2018). A “motion in limine should not be used to resolve factual disputes or weigh evidence.” IGT v. Alliance Gaming Corp., No. 2:04-cv-1676-RCJ-RJJ, 2008 WL 7084605, at *2 (D. Nev. Oct. 21, 2008). “To exclude evidence on a motion in limine, ‘the evidence must be inadmissible on all potential grounds.'” Diamond X Ranch, 2018 WL 2127734, at *1 (quoting Indiana Ins. Co. v. General Elec. Co., 326 F.Supp.2d 844, 846 (N.D. Ohio 2004)).
Plaintiff is correct that Nevada has “adopt[ed] a per se rule barring the admission of a collateral source of payment for an injury into evidence for any purpose.” Proctor v. Castelletti, 911 P.2d 853, 854 (Nev. 1996). It concluded that “[collateral source evidence inevitably prejudices the jury because it greatly increases the likelihood that a jury will reduce a plaintiffs award of damages because it knows the plaintiff is already receiving compensation.” Id. Federal courts likewise have adopted the collateral source rule. See Eichel v. New York Cent. R. Co., 375 U.S. 253, 255 (1963) (stating that evidence the plaintiff is receiving benefits from a collateral source is prejudicial); Russo v. Matson Nov. Co., 486 F.2d 1018, 1020 (9th Cir. 1973) (stating that “where the injured plaintiff's compensation comes from a collateral source, it should not be offset against the sum awarded for the tort nor considered in determining that award”).
However, evidence that Plaintiff was treated by physicians who hold medical liens does not, in and of itself, violate the collateral source rule. Evidence of the existence of a medical lien does not suggest a third-party source of payment; rather, it evidences “an unpaid bill.” Calvert v. Ellis, 2016 WL 153044 at *4 (D. Nev. January 12, 2016). Thus, the existence of a lien could implicate the lienholder's credibility (i.e., whether the lien-holding witness is testifying in order to help plaintiff recover funds to pay the lien). Id. Therefore, Defendants are not precluded from asking Plaintiff's treating physicians who are also retained experts whether they hold a medical lien and in what amount. Nor are they precluded from arguing that the physicians may be biased because they have an incentive to assist Plaintiff in maximizing recovery in this case. Expert compensation is relevant and admissible as it may impact bias. Id.
III. Conclusion
Accordingly, IT IS HEREBY ORDERED that Plaintiff's Motion in Limine No. 2 (#98) is DENIED.